Faculty profile

Gary Hunter

Back to faculty

Associate ProfessorDepartment of MedicineUniversity of Saskatchewan

Gary Hunter

Associate Professor

Department of Medicine

University of Saskatchewan

Saskatoon, Saskatchewan, Canada

Supervision signals

Professors usually supervise graduate students in their department's programs.
34 publications in the last five years, latest in 2026.
Senior (last) author on 1 recent paper, a sign of leading a research group.

These signals come from public records, including federal and provincial funding decisions. Ask the professor or the graduate program whether they are taking new students.

Academic metrics

Publications

1,160

Citations

122

Collaborators

Grants

Publications by year

Counts cover the publications linked to this profile. Citations and the h-index appear when the source records them.

Roles and appointments

Division Head, Neurology

Profiles and links

University Profile Google Scholar

Search on ResearchGate

iDORCID OpenAlex

Find them onX · LinkedIn · Bluesky · YouTube

Signals and details

Research

Read how they describe their research on their University of Saskatchewan profile.

Continuous EEG in Neurocritical Care and After Cardiac Arrest Nonconvulsive Status Epilepticus Acute Stroke

Latest papers

Association Between Ipsilateral Stroke and Nonstenotic (<50%) Carotid Disease: Secondary Analysis From the AcT Trial
Journal of the American Heart Association · 2026
Radiological thrombus characteristics and the effect of tenecteplase versus alteplase on outcomes in acute ischemic stroke.
International Journal of Stroke · 2026
Cerebral Amyloid Angiopathy Imaging Markers, Radiological Boston Criteria, and Thrombolysis Outcomes in Ischemic Stroke
Stroke · 2026

All 51 publications

Latest funding

A randomized controlled trial of adjunctive intraarterial tenecteplase vs standard of care following endovascular thrombectomy in patients with large vessel occlusion stroke (REACT)
CIHR · 2024 · Co-investigator
$1,407,600
A Multicentre, Randomized, Double-blinded, Placebo-controlled, Parallel Group, Single-dose Design to Determine the Efficacy and Safety of NoNO-42 in Participants with Acute Ischemic Stroke Selected for Thrombolysis
CIHR · 2023 · Co-investigator
$4,048,545
A Multicentre, Randomized, Double-blinded, Placebo-controlled, Parallel Group, Single-dose Design to Determine the Efficacy and Safety of NoNO-42 in Participants with Acute Ischemic Stroke Selected for Thrombolysis
CIHR · 2023 · Co-investigator
$1,012,136

All 6 grants and awards

51 publications.

Association Between Ipsilateral Stroke and Nonstenotic (<50%) Carotid Disease: Secondary Analysis From the AcT Trial

Ignacio KHD, Nagendra S, Bala F, Alhabli I, Kaveeta C, Tanaka K, Baguley E, Poulin T, Sjonnesen K, Horn M

Journal of the American Heart Association20261 citationsOpen Access

DOI: 10.1161/jaha.125.042821

Radiological thrombus characteristics and the effect of tenecteplase versus alteplase on outcomes in acute ischemic stroke.

Bala F, Ignacio K, Singh N, Alhabli I, Benali F, Khosravani H, Ganesh A, Tkach A, Catanese L, Dowlatshahi D

International Journal of Stroke2026

DOI: 10.1177/17474930261473813

Cerebral Amyloid Angiopathy Imaging Markers, Radiological Boston Criteria, and Thrombolysis Outcomes in Ischemic Stroke

Marzoughi S, Alhabli I, Singh N, Bala F, Betzner W, Lam K, Buck B, Catanese L, Tkach A, Dowlatshahi D

Stroke2026

DOI: 10.1161/strokeaha.125.054654

Comparing Clinical Characteristics and Outcomes of Tenecteplase Versus Alteplase in Young Adult Patients With Stroke: A Secondary Analysis of the AcT Trial

Ignacio KHD, Bala F, Catanese L, Tkach A, Kate M, Buck B, Ademola A, Sajobi TT, Field TS, Pikula A

Stroke: Vascular and Interventional Neurology2026Open Access

DOI: 10.1161/svin.125.001974

Intravenous Thrombolysis at Primary Stroke Centers Versus Comprehensive Stroke Centers: Analysis From the AcT Trial.

Gutiérrez D, Ignacio KHD, Tkach A, Manosalva Alzate HA, Ganesh A, Horn M, Khosravani H, Shankar J, Bala F, Tarek MA

Canadian Journal of Neurological Sciences2026Open Access

DOI: 10.1017/cjn.2026.10590

Association of 24-Hour Computed Tomography Infarct Density on Functional Outcomes in Stroke: Secondary Analysis From the AcT Trial.

Pensato U, Zhang J, Barakhanov K, Tanaka K, Bala F, Kaveeta C, Almekhlafi M, Dowlatshahi D, Field TS, Tkach A, Swartz R, Hunter G, Shankar JJS, Ademola A, Shamy M, Hu SX, Gubitz G, Demchuk AM, Menon BK, Ganesh A, Singh N

Journal of the American Heart Association2026

DOI: 10.1161/jaha.125.046038 PMID: 42179273

Brain Frailty and Functional Outcomes After Thrombolysis for Acute Ischemic Stroke

Loewen SP, Singh N, Alhabli I, Bala F, Buck B, Benali F, Betzner W, Lam K, Catanese L, Tkach A

JAMA Network Open202516 citationsOpen Access

DOI: 10.1001/jamanetworkopen.2025.34941 PMID: W4414653433

Thrombolysis With Tenecteplase for Minor Disabling Stroke

Zhang Y, Buck BH, Barber PA, Chatterjee K, Clarke B, Choi PMC, Hunter G, Ganesh A, Mishra SM, Williams D

JAMA Neurology20258 citations

DOI: 10.1001/jamaneurol.2025.4152 PMID: W4415590889

Feasibility of telephone and computerized cognitive testing as a secondary outcome in an acute stroke clinical trial: A mixed methods sub-study of the AcT Trial

Sujanthan S, Puveendrakumaran P, Dainty KN, Barense M, Lanctot KL, Owen AM, Singh N, Buck BH, Khosravani H, Coutts SB

European Stroke Journal20257 citationsOpen Access

DOI: 10.1177/23969873251323171

Safety, Functional Disability, Healthcare Utilization, and Quality-of-Life Outcomes in Elderly Receiving Alteplase and Tenecteplase: A Secondary Analysis From the AcT Trial

Singh N, Bala F, Ademola A, Almekhlafi M, Coutts SB, Deschaintre Y, Khosravani H, Buck BH, Appireddy R, Moreau F

Stroke20257 citationsOpen Access

DOI: 10.1161/strokeaha.124.049512

Profile data last refreshed on September 29, 2026 from the university directory, publication records and public research funding records.

Something wrong or missing on this profile? Suggest a correction

Gary Hunter

Research

Latest papers

Latest funding

Association Between Ipsilateral Stroke and Nonstenotic (<50%) Carotid Disease: Secondary Analysis From the AcT Trial

Radiological thrombus characteristics and the effect of tenecteplase versus alteplase on outcomes in acute ischemic stroke.

Cerebral Amyloid Angiopathy Imaging Markers, Radiological Boston Criteria, and Thrombolysis Outcomes in Ischemic Stroke

Comparing Clinical Characteristics and Outcomes of Tenecteplase Versus Alteplase in Young Adult Patients With Stroke: A Secondary Analysis of the AcT Trial

Intravenous Thrombolysis at Primary Stroke Centers Versus Comprehensive Stroke Centers: Analysis From the AcT Trial.

Association of 24-Hour Computed Tomography Infarct Density on Functional Outcomes in Stroke: Secondary Analysis From the AcT Trial.

Brain Frailty and Functional Outcomes After Thrombolysis for Acute Ischemic Stroke

Thrombolysis With Tenecteplase for Minor Disabling Stroke

Feasibility of telephone and computerized cognitive testing as a secondary outcome in an acute stroke clinical trial: A mixed methods sub-study of the AcT Trial

Safety, Functional Disability, Healthcare Utilization, and Quality-of-Life Outcomes in Elderly Receiving Alteplase and Tenecteplase: A Secondary Analysis From the AcT Trial

A randomized controlled trial of adjunctive intraarterial tenecteplase vs standard of care following endovascular thrombectomy in patients with large vessel occlusion stroke (REACT)

A Multicentre, Randomized, Double-blinded, Placebo-controlled, Parallel Group, Single-dose Design to Determine the Efficacy and Safety of NoNO-42 in Participants with Acute Ischemic Stroke Selected for Thrombolysis

A Multicentre, Randomized, Double-blinded, Placebo-controlled, Parallel Group, Single-dose Design to Determine the Efficacy and Safety of NoNO-42 in Participants with Acute Ischemic Stroke Selected for Thrombolysis

AcT-Cog: Online cognitive assessment in the Alteplase compared to Tenecteplase (AcT) trial.

TEMPO-2 - A randomized controlled trial of TNK-tPA versus standard of care for minor ischemic stroke with proven occlusion.

TEMPO-2 - A randomized controlled trial of TNK-tPA versus standard of care for minor ischemic stroke with proven occlusion

Frequent collaborators

Nishita Singh

Richard Swartz

Dar Dowlatshahi

Mohammed Almekhlafi

Brian Buck

Luciana Catanese

Dariush Dowlatshahi

Houman Khosravani

Thalia Field

Tolulope Sajobi

Bijoy Menon

Michel Shamy

Ramana Appireddy

Michael Hill

Michael Hill

Shelagh Coutts

Aleksandra Pikula

Aravind Ganesh

Andrew Demchuk

Jennifer Mandzia

Michael Kelly

Layla Gould

Gary Linassi

Ronald Borowsky